Clinical Trials Directory

The Clinical Effect of Low-Intensity Electromagnetic Field Neurostimulation in Fibromyalgia Syndrome Patients

ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST)

Effect of Transcranial Magnetic Stimulation on Free Will

Metabolic Effects of Acute Cortisol Withdrawal in Adrenal Failure

Comparison of Telerehabilitation and Video Basics and Exercise in Older Adult Individuals

Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis

Improved Stroke Outcome at 6 Months

Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy (TOT) Trial.

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

Developmental Study on Fatigue in Cancer

Safety of Thoracoscopy in Patients With High Risk

A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women

Retrospective Review of the Outcomes of Newborns With Genetic Abnormalities

Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma

Prevention of Errors in Resuscitation Medications Orders by Means of a Computerized Physician Order Entry

Terbinafine HCl 250 mg Tablet Under Fasting Conditions

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

Disulfiram in Patients With Metastatic Melanoma

Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study

Tracheobronchomalacia: Treatment Outcomes

European Study in Bone Sarcoma Patients Over 40 Years

Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances

Spectral Optical Coherence Tomography Findings in Patients With Ocular Toxoplasmosis

Brain Activity During Production of Movement

A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen

Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica

Study of Transfusion-Transmitted Infections

Interhemispheric Interactions Associated With Performance of Voluntary Movements in Patients With Stroke Motor Disability

Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy

Reward-Related Processes and Brain Function

SarCNU in Treating Patients With Recurrent Malignant Glioma

Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes

Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

A Comparison of the Studer Pouch Versus the T-Pouch Orthotopic Neobladder Urinary Diversion in Bladder Cancer Patients

Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)

Lifestyle Intervention in Overweight Women

Long-term Outcome in Pediatric Surgical Bypass Grafting After Traumatic Injury and Tumor Resection

Vitamin D Levels and Survival in Cancer Patients

A Retrospective Study Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and Non-molding Suturing in Colostomy Surgery

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED)

ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis

Age Gene/Environment Susceptibility Reykjavik Study